Alembic Pharma says USFDA issues warning letter to clinical investigator at Vadodara facility

Shares of Alembic Pharmaceuticals Ltd ended at ₹830.65, down by ₹6.75, or 0.81%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *